In-Chul Kim
Corporate Officer/Principal bij KAINOS MEDICINE, INC.
Profiel
In-Chul Kim is currently the President & Chief Executive Officer at National OncoVenture.
He is also the Vice Chairman at Kainos Medicine, Inc., the Director at Institut Pasteur Korea Research Foundation, and the Chief Strategic Officer at Kainos Medicine, Inc. Dr. Kim holds a doctorate degree from the University of Illinois.
Actieve functies van In-Chul Kim
| Bedrijven | Functie | Begin |
|---|---|---|
| KAINOS MEDICINE, INC. | Corporate Officer/Principal | - |
Institut Pasteur Korea Research Foundation
 Institut Pasteur Korea Research Foundation BiotechnologyHealth Technology Institut Pasteur Korea Research Foundation provides research and development for the treatment of infectious and chronic diseases. It develops a technology-based approach to therapeutic development through cellular models, high content screening and medicinal chemistry. The company was founded on December 29, 2003 and is headquartered in Seongnam, South Korea. | Directeur/Bestuurslid | - |
| National OncoVenture | Algemeen Directeur | - |
Opleiding van In-Chul Kim
| University of Illinois | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| KAINOS MEDICINE, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Institut Pasteur Korea Research Foundation
Institut Pasteur Korea Research Foundation BiotechnologyHealth Technology Institut Pasteur Korea Research Foundation provides research and development for the treatment of infectious and chronic diseases. It develops a technology-based approach to therapeutic development through cellular models, high content screening and medicinal chemistry. The company was founded on December 29, 2003 and is headquartered in Seongnam, South Korea. | Health Technology |
| National OncoVenture |
